Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Yorke
    Yorke
  10. Wu
    Wu

Groups

  1. Department of Medicine (4613)
  2. Surgery (3547)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2652)
  5. Radiation Oncology, Department of (2124)
  6. GSK Faculty (1936)
  7. Center for Hematologic Malignancies (1672)
  8. Hematologic Malignancies, Division of (1609)
  9. Gynecology Disease Management Team (1426)
  10. Sloan Kettering Institute Faculty (1398)
Search Within
Formats
  1. Journal Article (7394)
  2. Meeting Abstract (4692)
  3. Review (620)
  4. Book Section (538)
  5. Editorial (251)
  6. Conference Paper (140)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4613)
  2. Surgery (3547)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2652)
  5. Radiation Oncology, Department of (2124)
  6. GSK Faculty (1936)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (263)
  2. 2024 (784)
  3. 2023 (760)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2614)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (970)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (525)
  6. Journal of Sexual Medicine (435)

More Publications

Results (13867)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line pembrolizumab or placebo combined with etoposide and platinum for ES-SCLC: KEYNOTE-604 long-term follow-up results
    Meeting Abstract

    Rudin, C. M.; Kim, H. R.; Navarro, A.; Gottfried, M.; Peters, S.; Csőszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Czyżewicz, G.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • T-cell dynamics in response to neoadjuvant atezolizumab in early NSCLC by antigen response and T-cell receptor sequencing
    Meeting Abstract

    Oezkan, F.; Hilz, S.; Grindheim, J.; Wallace, A.; Seweryn, M.; Reuben, A.; Zhang, J.; Owen, D. H.; Nicholas, A.; Yadav, M.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Lobar or sub-lobar resection for peripheral clinical stage IA = 2 cm non-small cell lung Cancer (NSCLC): Results from an international randomized phase III trial (CALGB 140503 [Alliance])
    Meeting Abstract

    Altorki, N. K.; Wang, X.; Kozono, D.; Watt, C.; Landreneau, R.; Wigle, D.; Port, J.; Jones, D. R.; Conti, M.; Ashrafi, A. S.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Sotorasib in combination with RMC-4630, a SHP2 inhibitor, in KRAS p.G12C-mutated NSCLC and other solid tumors
    Meeting Abstract

    Falchook, G.; Li, B. T.; Marrone, K. A.; Bestvina, C. M.; Langer, C. J.; Krauss, J. C.; Strickler, J. H.; Meloni, A.; Dai, T.; Varrieur, T.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Long-term results of a multi-institutional phase II study of hypofractionated proton beam irradiation of unresectable primary liver tumors
    Meeting Abstract

    Roberts, H. J.; Hong, T. S.; Ly, L.; Yeap, B. Y.; Ben-Josef, E.; Zhu, A. X.; Goyal, L.; Franses, J.; Ryan, D. P.; Allen, J. N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Retinopathy, optic neuropathy and cataract in childhood cancer survivors treated with radiotherapy: A report from the pediatric normal tissue effects in the clinic (PENTEC) initiative
    Meeting Abstract

    Shen, C.; Kry, S.; Buchsbaum, J.; Milano, M. T.; Inskip, P.; Francis, J. H.; Wilson, M. W.; Whelan, K.; Mayo, C.; Olch, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for oligometastasis: GUst do it?
    Editorial

    Glicksman, R. M.; Palma, D. A.; Deek, M. P.; Tsai, C. J.; Chmura, S.; Siva, S.; Ost, P.; Tran, P. T.; Berlin, A.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • A tale of competing risk management
    Editorial

    Oladeru, O. T.; Yerramilli, D.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • A multicenter prospective trial of diffusing alpha-emitter radiation therapy for recurrent or unresectable cutaneous cancers: Early results from a pilot feasibility study in the United States
    Meeting Abstract

    Barker, C. A.; D'Andrea, M. A.; Patra, P.; Cohen, G.; Damanto, A.; Ballo, M. T.; VanderWalde, N. A.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save